pustular psoriasis

Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis
Palmoplantar Pustulosis
by NEXT STEPS IN DERM TEAM on
Palmoplantar pustulosis (PPP) is a rare, recurrent skin disorder that presents a major challenge to clinical therapy. JDD author Danilo C. Del Campo, MD, FAAD reports a case of a 69-year-old woman with a 20-year history of psoriasis with skin manifestations and clinical and pathologic features consistent with PPP. After intolerance to apremilast and unsuccessful use of topical corticosteroids and …
A WHOLE-istic View to Managing Psoriasis in the Era of COVID-19
Managing Psoriasis in the Era of Covid-19
by Matthew Willett, MD, FAAD on
As part of the recent 2020 Integrative Dermatology Symposium, Dr. Jason Hawkes, Associate Clinical Professor of Dermatology at UC Davis, provided a fantastically comprehensive primer on the management of psoriasis in the COVID-19 era. Read on for important treatment recommendations and insights to improve your clinical practice! As an introduction, Dr. Hawkes emphasized that psoriasis remains a …
Interleukin-17 Inhibitors Therapeutic Cheat Sheet
Interleukin-17
by Angelo Landriscina, MD on
Biologics have revolutionized the treatment of psoriasis, and with new entries into the class, PASI90 and 100 have become attainable for many patients.  In this installment of our Therapeutic Cheat Sheet series, we’ll cover everything you need to know to start and monitor your patients on IL-17 blocking therapies. [caption id="attachment_8301" align="alignleft" width="612"] Click image to en …